| TSST-1 | Toxic Shock Syndrome Toxin-1 = Enterotoxin type F |
|---|---|
| ANSWER | Agency for Toxic Substances and Disease Registry/National Library of Medicine's Workstation for Emer... |
| ATA | alimentary toxic aleukia; American Thyroid Association; aminotriazole; antithymic activity; antithyr... |
| ATE | acute toxic encephalopathy; adipose tissue extract; autologous tumor extract |
| ATSDR | Agency for Toxic Substances and Disease Registry |
| effect, founder | A population group with an unusual frequency of a gene due to there having been only a small number of original members ( founders ) one or more of whom had that gene. For example, the gene for Huntington disease was introduced into the Lake Maracaibo region of Venezuela early in the 19th century, so there are now over a hundred persons with Huntington disease and at least 900 persons at risk for that deadly disease in that region, the largest known aggregation known in the world with the Huntington gene. (12 Dec 1998) |
|---|---|
| effect modifier | A factor that modifies the effect of a putative causal factor under study; e.g., age is an effect modifier for many conditions. (05 Mar 2000) |
| effect modifiers | <epidemiology> Factors that modify the effect of the putative causal factor(s) under study. (12 Dec 1998) |
| electrophonic effect | The sensation of hearing produced when an alternating current of suitable frequency and magnitude is passed from an external source through a person. (05 Mar 2000) |
| enhancement effect | Property of higher plant photosynthesis, discovered by Robert Emerson. The quantum yield of red light (less than 680nm) and far red light (700nm), when shone simultaneously on a plant, is greater than the sum of the yields of the light of the two wavelengths separately. This effect provides evidence for the cooperative interaction of two photosystems in photosynthesis. (18 Nov 1997) |
| tunneling effect | <radiobiology> In quantum mechanics, a particle approaching a potential energy barrier of finite extent has a chance (usually small) of tunneling through the barrier, even though it lacks the energy to go over the barrier. Tunneling plays a strong role in fusion reactions: particles which do not have enough energy to climb over the electrostatic energy barrier (into the region where nuclear attractions dominate) can still fuse by tunneling through. (09 Oct 1997) |
| Tyndall effect | The visibility of floating particles in gases or liquids when illuminated by a ray of sunlight and viewed at right angles to the illuminating ray. Synonym: Tyndall effect. (05 Mar 2000) |
| extrapyramidal effect | A combination of neurologic effects which includes tremors, chorea, athetosis and dystonia. A common side effect of neuroleptic agents (phenothiazines). Other medications known to cause these reactions include haloperidol, molindone, perphenazine & amitriptyline, loxapine, pimozide and rarely, benzodiazepines. (27 Sep 1997) |
| Fahraeus-Lindqvist effect | The decrease in apparent viscosity that occurs when a suspension, such as blood, is made to flow through a tube of smaller diameter; observed in tubes less than about 0.3 mm in diameter. Synonym: sigma effect. (05 Mar 2000) |
| Zeeman effect | The splitting of spectral lines into three or more symmetrically placed lines when the light source is subjected to a magnetic field. (05 Mar 2000) |
| Fenn effect | The increased liberation of heat in a stimulated muscle when it is allowed to do mechanical work; the amount of heat liberated is increased in proportion to the distance the muscle is allowed to shorten and in proportion to the tension it must develop (e.g., the weight it lifts) during shortening; thus increased chemical energy is consumed both to liberate increased heat and to do increased mechanical work. (05 Mar 2000) |
| zygotic effect gene | <genetics> A gene whose phenotype is dependent on the genotype of the zygote, rather than the genotype of the mother. See: maternal effect gene. (18 Nov 1997) |
| late effect | Side effects of chemotherapy and/or radiotherapy which only become apparent with long-term monitoring of the patient over a period of years. These are of particular concern in patients below the age of puberty. (18 Nov 1997) |
| founder effect | The establishment of a new population by a few original founders (in an extreme case, by a single fertilized female) which carry only a small fraction of the total genetic variation of the parental population [Ernst Mayr, 1963]. The result is that a given allele, gene, chromosome, or part of a chromosome found in members of the population can be traced back to one ancestral individual. (09 Oct 1997) |